Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orit Jacobson

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
<sup>177</sup>Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate CancerJie Zang, Qingxing Liu, Huimin Sui, et al.
Molecular Imaging and Biology|July 2, 2015
Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 ExpressionXuefeng Yan, Gang Niu, Zhe Wang, et al.
Nuclear Medicine and Biology|April 20, 2004
Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumorsEyal Mishani, Galith Abourbeh, Yulia Rozen, et al.
Theranostics|October 5, 2016
Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor DeliveryXiao Tong, Zhantong Wang, Xiaolian Sun, et al.
Journal of Medicinal Chemistry|August 5, 2005
High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumorsEyal Mishani, Galith Abourbeh, Orit Jacobson, et al.
Nuclear Medicine and Biology|January 11, 2007
Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumorsGalith Abourbeh, Samar Dissoki, Orit Jacobson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog <sup>177</sup>Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine TumorsJingjing Zhang, Hao Wang, Orit Jacobson, et al.
Theranostics|January 3, 2017
Improved Tumor Uptake by Optimizing Liposome Based RES Blockade StrategyXiaolian Sun, Xuefeng Yan, Orit Jacobson, et al.
Bioconjugate Chemistry|February 23, 2011
Rapid and simple one-step F-18 labeling of peptidesOrit Jacobson, Lei Zhu, Ying Ma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2021
Photodynamic-Chemodynamic Cascade Reactions for Efficient Drug Delivery and Enhanced Combination TherapySheng Wang, Guocan Yu, Weijing Yang, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
<sup>177</sup>Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate CancerJie Zang, Qingxing Liu, Huimin Sui, et al.
Molecular Imaging and Biology|July 2, 2015
Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 ExpressionXuefeng Yan, Gang Niu, Zhe Wang, et al.
Nuclear Medicine and Biology|April 20, 2004
Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumorsEyal Mishani, Galith Abourbeh, Yulia Rozen, et al.
Theranostics|October 5, 2016
Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor DeliveryXiao Tong, Zhantong Wang, Xiaolian Sun, et al.
Journal of Medicinal Chemistry|August 5, 2005
High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumorsEyal Mishani, Galith Abourbeh, Orit Jacobson, et al.
Nuclear Medicine and Biology|January 11, 2007
Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumorsGalith Abourbeh, Samar Dissoki, Orit Jacobson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog <sup>177</sup>Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine TumorsJingjing Zhang, Hao Wang, Orit Jacobson, et al.
Theranostics|January 3, 2017
Improved Tumor Uptake by Optimizing Liposome Based RES Blockade StrategyXiaolian Sun, Xuefeng Yan, Orit Jacobson, et al.
Bioconjugate Chemistry|February 23, 2011
Rapid and simple one-step F-18 labeling of peptidesOrit Jacobson, Lei Zhu, Ying Ma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2021
Photodynamic-Chemodynamic Cascade Reactions for Efficient Drug Delivery and Enhanced Combination TherapySheng Wang, Guocan Yu, Weijing Yang, et al.
Pageof 15